Targeting Apolipoprotein E for Alzheimer’s Disease: An Industry Perspective
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Apolipoprotein E for Alzheimer’s Disease: An Industry Perspective
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 9, Pages 2161
Publisher
MDPI AG
Online
2019-05-02
DOI
10.3390/ijms20092161
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A walk through tau therapeutic strategies
- (2019) Santosh Jadhav et al. Acta Neuropathologica Communications
- ApoE attenuates unresolvable inflammation by complex formation with activated C1q
- (2019) Changjun Yin et al. NATURE MEDICINE
- Dr. Jekyll and Mr. Hyde: ApoE explains opposing effects of neuronal LRP1
- (2019) Michael R. Strickland et al. JOURNAL OF CLINICAL INVESTIGATION
- Blood will out: vascular contributions to Alzheimer’s disease
- (2018) Sidney Strickland JOURNAL OF CLINICAL INVESTIGATION
- Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation
- (2018) Fan Liao et al. JOURNAL OF CLINICAL INVESTIGATION
- Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease
- (2018) Brad T. Casali et al. Journal of Neuroinflammation
- Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector
- (2018) Chengzhong Wang et al. NATURE MEDICINE
- Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
- (2018) Melanie D. Sweeney et al. Nature Reviews Neurology
- Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion
- (2018) Erica Dresselhaus et al. PLoS One
- Defective cholesterol clearance limits remyelination in the aged central nervous system
- (2018) Ludovico Cantuti-Castelvetri et al. SCIENCE
- White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes
- (2018) Grégory Operto et al. Alzheimers Research & Therapy
- APOE and AβPP Gene Variation in Cortical and Cerebrovascular Amyloid-β Pathology and Alzheimer's Disease: A Population-Based Analysis
- (2018) Terhi Peuralinna et al. JOURNAL OF ALZHEIMERS DISEASE
- Improvement of Memory Deficits and Amyloid-β Clearance in Aged APP23 Mice Treated with a Combination of Anti-Amyloid-β Antibody and LXR Agonist
- (2018) Nicholas F. Fitz et al. JOURNAL OF ALZHEIMERS DISEASE
- Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function
- (2018) Kenzo Koizumi et al. Nature Communications
- The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives
- (2018) Cody Wolfe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease
- (2018) Xunde Xian et al. eLife
- APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes
- (2017) Jing Zhao et al. HUMAN MOLECULAR GENETICS
- ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice
- (2017) Nicholas F. Fitz et al. JOURNAL OF ALZHEIMERS DISEASE
- The role of APOE on lipid homeostasis and inflammation in normal brains
- (2017) G. William Rebeck JOURNAL OF LIPID RESEARCH
- ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
- (2017) Yang Shi et al. NATURE
- Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosis
- (2017) Tien-Phat V. Huynh et al. NEURON
- Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes
- (2017) Na Zhao et al. NEURON
- ApoE4 Accelerates Early Seeding of Amyloid Pathology
- (2017) Chia-Chen Liu et al. NEURON
- Central Nervous System LipoproteinsHighlights
- (2016) Robert W. Mahley ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice
- (2016) Jérôme Robert et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Apolipoprotein E as a Therapeutic Target in Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
- (2016) Yu Yamazaki et al. CNS DRUGS
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies
- (2016) Anat Boehm-Cagan et al. JOURNAL OF ALZHEIMERS DISEASE
- Genetic Restoration of Plasma ApoE Improves Cognition and Partially Restores Synaptic Defects in ApoE-Deficient Mice
- (2016) C. Lane-Donovan et al. JOURNAL OF NEUROSCIENCE
- Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse
- (2016) Ye Zhang et al. NEURON
- Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study
- (2016) Bolun Li et al. PLoS One
- Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes
- (2016) Won-Suk Chung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
- (2016) Y. Iturria-Medina et al. Nature Communications
- Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease
- (2016) Jeffrey L. Cummings et al. Alzheimers Research & Therapy
- Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes
- (2016) Jianjia Fan et al. PLoS One
- Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele
- (2015) Sana Suri et al. Alzheimers & Dementia
- Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease
- (2015) Liv Tybjærg Nordestgaard et al. Alzheimers & Dementia
- Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
- (2015) Yuka Atagi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
- (2015) Charles C. Bailey et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice
- (2015) Angela W. Corona et al. Journal of Neuroimmune Pharmacology
- Apolipoprotein E, Carbon Dioxide Vasoreactivity, and Cognition in Older Adults: Effect of Hypertension
- (2015) Ihab Hajjar et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice
- (2015) De-shan Liu et al. Molecular Neurodegeneration
- High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer’s Disease
- (2014) Sophie Stukas et al. Cell Metabolism
- Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: AnN= 725 surface-based Alzheimer's disease neuroimaging initiative study
- (2014) Jie Shi et al. HUMAN BRAIN MAPPING
- An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
- (2014) Y. Zhang et al. JOURNAL OF NEUROSCIENCE
- Apolipoprotein E4 Produced in GABAergic Interneurons Causes Learning and Memory Deficits in Mice
- (2014) J. Knoferle et al. JOURNAL OF NEUROSCIENCE
- Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function
- (2014) Angel C. Y. Mak et al. JAMA Neurology
- The APOE ε4/ε4 Genotype Potentiates Vascular Fibrin(Ogen) Deposition in Amyloid-Laden Vessels in the Brains of Alzheimer's Disease Patients
- (2013) Karin Hultman et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Examination of the Clinicopathologic Continuum of Alzheimer Disease in the Autopsy Cohort of the National Alzheimer Coordinating Center
- (2013) Alberto Serrano-Pozo et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- The Liver X Receptor Agonist GW3965 Improves Recovery from Mild Repetitive Traumatic Brain Injury in Mice Partly through Apolipoprotein E
- (2013) Dhananjay R. Namjoshi et al. PLoS One
- Effect of Apolipoprotein E Genotype and Diet on Apolipoprotein E Lipidation and Amyloid Peptides
- (2013) Angela J. Hanson et al. JAMA Neurology
- APOE genotype alters glial activation and loss of synaptic markers in mice
- (2012) Yuangui Zhu et al. GLIA
- Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
- (2012) Carlos Cruchaga et al. HUMAN MOLECULAR GENETICS
- Small-Molecule Structure Correctors Target Abnormal Protein Structure and Function: Structure Corrector Rescue of Apolipoprotein E4–Associated Neuropathology
- (2012) Robert W. Mahley et al. JOURNAL OF MEDICINAL CHEMISTRY
- Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
- (2012) Robert D. Bell et al. NATURE
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models
- (2012) P. E. Cramer et al. SCIENCE
- Liver X receptors regulate cholesterol homeostasis in oligodendrocytes
- (2011) Katherine Nelissen et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Linking lipids to Alzheimer's disease: cholesterol and beyond
- (2011) Gilbert Di Paolo et al. NATURE REVIEWS NEUROSCIENCE
- Lipids in Alzheimer's disease: A century-old story
- (2010) Paul Foley BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Modulation of ABCA1 by an LXR Agonist Reduces Beta-Amyloid Levels and Improves Outcome after Traumatic Brain Injury
- (2010) David J. Loane et al. JOURNAL OF NEUROTRAUMA
- ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling
- (2010) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- APOE and cholesterol homeostasis in Alzheimer's disease
- (2010) Valérie Leduc et al. TRENDS IN MOLECULAR MEDICINE
- Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
- (2009) Robert D. Bell et al. ACTA NEUROPATHOLOGICA
- Understanding the Basis for the Association of apoE4 with Alzheimers Disease: Opening the Door for Therapeutic Approaches
- (2009) Ning Zhong et al. Current Alzheimer Research
- Reduced levels of human apoE4 protein in an animal model of cognitive impairment
- (2009) P.M. Sullivan et al. NEUROBIOLOGY OF AGING
- Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease
- (2008) Suzanne E. Wahrle et al. JOURNAL OF CLINICAL INVESTIGATION
- Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
- (2008) D. R. Riddell et al. JOURNAL OF NEUROSCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started